transition from tirzepatide to retatrutide Switching retatrutide: the complete guide switching from retatrutide to tirzepatide

While patients require a medical history of MASH, liver biopsy might not be absolutely required for medication approval and may be supplemented by liver fibrosis imaging (transient elastography [FibroScan] or magnetic resonance elastography) and noninvasive fibrosis scoring (fibrosis-4 index)

These include: Personal or family history of medullary thyroid carcinoma Multiple endocrine neoplasia syndrome type 2 Active gallbladder disease or pancreatitis Uncontrolled gastrointestinal conditions Most healthy adults with weight concerns are eligible, but this layer of medical safety is why medically supervised weight loss is so vital

How much protein do I need on GLP-1 therapy

This painless test takes only a few minutes and helps us monitor your macular health over time

GLP-1 Receptor Agonists and Ocular Outcomes: Metabolic Transition, Retinal Vulnerability, and Risk-Stratified Monitoring